These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

71 related articles for article (PubMed ID: 22982091)

  • 1. Advanced glycation end products and lipofuscin deposits share the same location in cardiocytes of the failing heart.
    Nozynski J; Zakliczynski M; Konecka-Mrowka D; Zakliczynska H; Pijet M; Zembala-Nozynska E; Lange D; Zembala M
    Exp Gerontol; 2013 Feb; 48(2):223-8. PubMed ID: 22982091
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Advanced glycation end-products in myocardium-supported vessels: effects of heart failure and diabetes mellitus.
    Nożyński J; Zakliczyński M; Konecka-Mrówka D; Przybylski R; Zembala M; Zielińska T; Mrówka A; Lange D; Zembala-Nożyńska E; Nikiel B; Młynarczyk-Liszka J
    J Heart Lung Transplant; 2011 May; 30(5):558-64. PubMed ID: 21212000
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Advanced glycation end product accumulation in the cardiomyocytes of heart failure patients with and without diabetes.
    Nożyński J; Zakliczyński M; Konecka-Mrowka D; Zielinska T; Zakliczynska H; Nikiel B; Mlynarczyk-Liszka J; Mrowka A; Zembala-Nozynska E; Pijet M; Rdzanowska K; Lange D; Przybylski R; Zembala M
    Ann Transplant; 2012; 17(2):53-61. PubMed ID: 22743723
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Advanced glycation end products in the development of ischemic and dilated cardiomyopathy in patients with diabetes mellitus type 2.
    Nozyński J; Zakliczyński M; Konecka-Mrówka D; Nikiel B; Mlynarczyk-Liszka J; Zembala-Nozyńska E; Lange D; Maruszewski M; Zembala M
    Transplant Proc; 2009; 41(1):99-104. PubMed ID: 19249488
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Different role of advanced glycation end products in pathology of transplanted heart in patients with or without diabetes mellitus type 2.
    Zakliczynski M; Nozynski J; Konecka-Mrowka D; Pyka L; Trybunia D; Nikiel B; Mlynarczyk-Liszka J; Lange D; Zembala M
    Transplant Proc; 2009 Oct; 41(8):3185-9. PubMed ID: 19857706
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunohistochemical distribution and subcellular localization of three distinct specific molecular structures of advanced glycation end products in human tissues.
    Ling X; Sakashita N; Takeya M; Nagai R; Horiuchi S; Takahashi K
    Lab Invest; 1998 Dec; 78(12):1591-606. PubMed ID: 9881959
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Diastolic stiffness of the failing diabetic heart: importance of fibrosis, advanced glycation end products, and myocyte resting tension.
    van Heerebeek L; Hamdani N; Handoko ML; Falcao-Pires I; Musters RJ; Kupreishvili K; Ijsselmuiden AJ; Schalkwijk CG; Bronzwaer JG; Diamant M; Borbély A; van der Velden J; Stienen GJ; Laarman GJ; Niessen HW; Paulus WJ
    Circulation; 2008 Jan; 117(1):43-51. PubMed ID: 18071071
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Paradox of advanced glycation end-products in late cardiac biopsies of heart transplant recipients.
    Zakliczynski M; Nozynski J; Konecka-Mrowka D; Lange D; Zakliczynska H; Szygula-Jurkiewicz B; Zembala M
    Transplant Proc; 2011 Oct; 43(8):3058-60. PubMed ID: 21996224
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Advanced glycation end product (AGE) accumulation on Bruch's membrane: links to age-related RPE dysfunction.
    Glenn JV; Mahaffy H; Wu K; Smith G; Nagai R; Simpson DA; Boulton ME; Stitt AW
    Invest Ophthalmol Vis Sci; 2009 Jan; 50(1):441-51. PubMed ID: 18676633
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Autofluorescence characterization of advanced glycation end products of hemoglobin.
    Vigneshwaran N; Bijukumar G; Karmakar N; Anand S; Misra A
    Spectrochim Acta A Mol Biomol Spectrosc; 2005 Jan; 61(1-2):163-70. PubMed ID: 15556435
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunohistochemical study of human advanced glycation end-products (AGE) and growth factors in cardiac tissues of patients on maintenance dialysis and with kidney transplantation.
    Yoshida S; Yamada K; Hamaguchi K; Nishimura M; Hatakeyama E; Tsuchida H; Sakamoto K; Kashiwabara H; Yokoyama T; Ikeda K; Horiuchi S
    Clin Nephrol; 1998 May; 49(5):273-80. PubMed ID: 9617488
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Relationship between autofluorescence and advanced glycation end products in diabetic lenses.
    Abiko T; Abiko A; Ishiko S; Takeda M; Horiuchi S; Yoshida A
    Exp Eye Res; 1999 Mar; 68(3):361-6. PubMed ID: 10079144
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Increased levels of vascular endothelial growth factor and advanced glycation end products in aqueous humor of patients with diabetic retinopathy.
    Endo M; Yanagisawa K; Tsuchida K; Okamoto T; Matsushita T; Higuchi M; Matsuda A; Takeuchi M; Makita Z; Koike T
    Horm Metab Res; 2001 May; 33(5):317-22. PubMed ID: 11440280
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Paradox of circulating advanced glycation end product concentrations in patients with congestive heart failure and after heart transplantation.
    Heidland A; Sebeková K; Frangiosa A; De Santo LS; Cirillo M; Rossi F; Cotrufo M; Perna A; Klassen A; Schinzel R; De Santo NG
    Heart; 2004 Nov; 90(11):1269-74. PubMed ID: 15486118
    [TBL] [Abstract][Full Text] [Related]  

  • 15. L-type calcium currents of human myocytes from ventricle of non-failing and failing hearts and from atrium.
    Mewes T; Ravens U
    J Mol Cell Cardiol; 1994 Oct; 26(10):1307-20. PubMed ID: 7869391
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Pathology of heart transplantation.(Morphological study of 1246 endomyocardial biopsies from 167 transplanted hearts). Causes of early, intermediate, and late deaths].
    Agozzino L; Thomopoulos K; Esposito S; Agozzino M; De Vivo F; Maiello C; Cotrufo M
    Pathologica; 1999 Apr; 91(2):89-100. PubMed ID: 10484868
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Increased serum high-mobility group box-1 and cleaved receptor for advanced glycation endproducts levels and decreased endogenous secretory receptor for advanced glycation endproducts levels in diabetic and non-diabetic patients with heart failure.
    Wang LJ; Lu L; Zhang FR; Chen QJ; De Caterina R; Shen WF
    Eur J Heart Fail; 2011 Apr; 13(4):440-9. PubMed ID: 21266376
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Vascular abnormalities and cardiomyocyte lipofuscin deposits in endomyocardial biopsy specimens of heart transplant recipients: are they related to the development of cardiac allograft vasculopathy?
    Zakliczynski M; Nozynski J; Konecka-Mrowka D; Krynicka-Mazurek A; Swierad M; Maruszewski M; Przybylski R; Zembala M
    J Thorac Cardiovasc Surg; 2009 Jul; 138(1):215-21, 221.e1-3. PubMed ID: 19577082
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Secretory products from epicardial adipose tissue of patients with type 2 diabetes mellitus induce cardiomyocyte dysfunction.
    Greulich S; Maxhera B; Vandenplas G; de Wiza DH; Smiris K; Mueller H; Heinrichs J; Blumensatt M; Cuvelier C; Akhyari P; Ruige JB; Ouwens DM; Eckel J
    Circulation; 2012 Nov; 126(19):2324-34. PubMed ID: 23065384
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Advanced glycation end-products (AGEs) and heart failure: pathophysiology and clinical implications.
    Hartog JW; Voors AA; Bakker SJ; Smit AJ; van Veldhuisen DJ
    Eur J Heart Fail; 2007 Dec; 9(12):1146-55. PubMed ID: 18023248
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.